Regression of kaposiform lymphangiomatosis and chronic disseminated intravascular coagulation after inhaled budesonide-formoterol treatment

Pediatr Blood Cancer. 2024 Apr;71(4):e30907. doi: 10.1002/pbc.30907. Epub 2024 Jan 31.

Authors

Masaru Imamura¹, Chansu Shin¹, Michio Ozeki², Kentaro Matsuoka³, Akihiko Saitoh¹, Chihaya Imai¹

Affiliations

¹ Department of Pediatrics, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
² Department of Pediatrics, Graduate School of Medicine, Gifu University, Gifu, Japan.
³ Department of Pathology, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan.

PMID: 38296836
DOI: 10.1002/pbc.30907

No abstract available

Publication types

Letter

MeSH terms

Administration, Inhalation
Bronchodilator Agents / therapeutic use
Budesonide
Disseminated Intravascular Coagulation* / drug therapy
Double-Blind Method
Formoterol Fumarate
Humans

Substances

Bronchodilator Agents
Budesonide
Formoterol Fumarate